HTD1801, a First-in-Class Anti-inflammatory Metabolic Modulator, Demonstrates Durable 52-Week Efficacy and Safety in Two Phase III Trials in Type 2 Diabetes Mellitus HighTide Therapeutics Inc. Oct 31, 2025 08:30 HKT/SGT Read More
CMS (867.HK; 8A8.SG) NDA for AD Indication of Long-acting Anti-IL-4Ra Humanized Monoclonal Antibody Injection MG-K10 Accepted in China China Medical System Holdings Limited Oct 30, 2025 21:00 JST Read More
Olympus Introduces NBI+TXI(TM) Observation Mode to the EVIS X1(TM) Endoscopy System CV-1500 Video System Center Olympus Oct 30, 2025 16:00 HKT/SGT Read More
Eisai and Merck & Co., Inc., Rahway, NJ, USA Provide Update on Phase 3 LEAP012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma Eisai Oct 30, 2025 13:43 HKT/SGT Read More
Olympus Introduces NBI+TXI(TM) Observation Mode to the EVIS X1(TM) Endoscopy System CV-1500 Video System Center Olympus Oct 29, 2025 10:00 HKT/SGT Read More
Merck & Co., Inc. and Eisai Announce WELIREG(R) (belzutifan) Plus LENVIMA(R) (lenvatinib) Met Primary Endpoint of Progression-Free Survival (PFS) in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma Eisai Oct 28, 2025 23:30 HKT/SGT Read More
Fujitsu AI transforms regional healthcare in Iki city Fujitsu Ltd Oct 28, 2025 22:24 HKT/SGT Read More
CMS (867.HK; 8A8.SG) Signed A Distribution Agreement for Ophthalmic Drugs Lucentis(R) and Beovu(R) China Medical System Holdings Limited Oct 27, 2025 23:00 JST Read More
Health Canada Grants Authorization for "LEQEMBI(R)" (lecanemab) for the Treatment of Early Alzheimer's Disease Eisai Oct 27, 2025 13:23 HKT/SGT Read More
FIG, Fujitsu, Acer Medical collaborate to develop health-promoting insurance concept to support preventative care in aging societies Fujitsu Ltd Oct 24, 2025 15:52 HKT/SGT Read More
Olympus Launches New Surgical Energy Device for Hemostatic Cutting and Vessel Sealing Olympus Oct 21, 2025 22:00 HKT/SGT Read More
Indonesia's Legacy in the Global Vaccine Landscape: Bio Farma and DCVMN Strengthen Health Resilience through Global Partnership PT Bio Farma (Persero) Oct 21, 2025 15:45 HKT/SGT Read More
Olympus: "Feasibility study on the development of Japanese digitalized endoscopy infection control systems in India" Selected for METI's FY2024 Supplementary "Global South Future-Oriented Co-Creation Subsidy Program (Small-Scale Demonstration / Feasibility Study Project)" Olympus Oct 21, 2025 10:00 HKT/SGT Read More
LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025" Eisai Oct 14, 2025 16:54 HKT/SGT Read More
Eisai and Biogen Announce U.S. Availability of LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer's Disease Eisai Oct 08, 2025 11:03 HKT/SGT Read More
Olympus Launches SecureFlex, a Single-use Fine Needle Biopsy Device Olympus Oct 06, 2025 14:00 HKT/SGT Read More
Eisai Highlights Breadth of Oncology Research at ESMO 2025 Eisai Oct 03, 2025 17:01 HKT/SGT Read More
DOCOMO and PaMeLa Develop World's First Technology to Share Pain Perception Tailored to Individual Sensitivity NTT DOCOMO Oct 01, 2025 21:18 HKT/SGT Read More
The Second Proton Therapy System Begins Treatment at University of Tsukuba Hospital Hitachi, Ltd. Oct 01, 2025 19:37 HKT/SGT Read More
